NASDAQ:BIS - ProShares UltraShort Nasdaq Biotechnology Stock Price Target and Predictions

  • Consensus Rating: N/A
  • Consensus Price Target: $0.00
  • Forecasted Upside: -100.00 %
  • Number of Analysts: 0
  • Breakdown:
  • 0 Sell Ratings
  • 0 Hold Ratings
  • 0 Buy Ratings
  • 0 Strong Buy Ratings
$17.98
▼ -0.29 (-1.59%)

This chart shows the closing price for BIS by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New ProShares UltraShort Nasdaq Biotechnology Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for BIS and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for BIS

Analyst Price Target is $0.00
▼ -100.00% Downside Potential
This price target is based on 0 analysts offering 12 month price targets for ProShares UltraShort Nasdaq Biotechnology in the last 3 months. The average price target is $0.00, with a high forecast of $0.00 and a low forecast of $10,000,000.00. The average price target represents a -100.00% upside from the last price of $17.98.

This chart shows the closing price for BIS for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart

Current Consensus is N/A

The current consensus among 0 polled investment analysts is to n/a stock in ProShares UltraShort Nasdaq Biotechnology. This N/A consensus rating has held steady for over two years.

Past Monthly Recommendations

Move your mouse over past months for details Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart

  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
1/29/2020
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
4/28/2020
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
7/27/2020
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
10/25/2020
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
1/23/2021
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
4/23/2021
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
6/22/2021
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
7/22/2021

Latest Recommendations

  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
7/19/2017Fundamental ResearchInitiated CoverageBuy ➝ Buy$0.64 ➝ $0.64N/A
(Data available from 7/23/2016 forward)

ProShares UltraShort Nasdaq Biotechnology

ProShares Ultra Nasdaq Biotechnology (the Fund) seeks investment results for a single day only, not for longer periods. The Fund seeks daily investment results, before fees and expenses, that correspond to twice (200%) the daily performance of the Index. The return of the Fund for a period longer than a single trading day will be the result of each day’s returns compounded over the period, which will very likely differ from twice (200%) the return of the Nasdaq Biotechnology Index (the Index) for that period. The Fund does not seek to achieve its stated investment objective over a period of time greater than one day. The Fund invests in equity securities and derivatives that have similar daily performance characteristics as twice (200%) the daily return of the Index. The Fund invests in financial instruments whose value is derived from the value of an underlying asset, interest rate or index. ProShare Advisors LLC is the investment advisor of the Fund.
Read More

Today's Range

Now: $17.98
Low: $17.98
High: $18.38

50 Day Range

MA: $19.81
Low: $17.97
High: $22.55

52 Week Range

Now: $17.98
Low: $17.53
High: $36.49

Volume

4,236 shs

Average Volume

59,267 shs

Market Capitalization

$8.02 million

P/E Ratio

N/A

Dividend Yield

0.00%

Beta

N/A

Frequently Asked Questions

What sell-side analysts currently cover shares of ProShares UltraShort Nasdaq Biotechnology?

The following Wall Street analysts have issued reports on ProShares UltraShort Nasdaq Biotechnology in the last twelve months:
View the latest analyst ratings for BIS.

What is the current price target for ProShares UltraShort Nasdaq Biotechnology?

0 Wall Street analysts have set twelve-month price targets for ProShares UltraShort Nasdaq Biotechnology in the last year. has the lowest price target set, forecasting a price of $10,000,000.00 for ProShares UltraShort Nasdaq Biotechnology in the next year.
View the latest price targets for BIS.

What is the current consensus analyst rating for ProShares UltraShort Nasdaq Biotechnology?

ProShares UltraShort Nasdaq Biotechnology currently has from Wall Street analysts. The stock has a consensus analyst rating of "N/A."
View the latest ratings for BIS.

How do I contact ProShares UltraShort Nasdaq Biotechnology's investor relations team?

ProShares UltraShort Nasdaq Biotechnology's physical mailing address is SUITE 1000, 7501 WISCONSIN AVENUE, Bethesda, MD 20814, United States. The company's listed phone number is +1-240-4976400. The official website for ProShares UltraShort Nasdaq Biotechnology is www.proshares.com.